MEDICLIN AG (MED.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:MED - DE0006595101 - Common Stock
MED.DE Key Statistics, Chart & Performance
The current stock price of MED.DE is 3.4 EUR. In the past month the price decreased by -6.08%. In the past year, price increased by 32.81%.
MED.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EMEIS.PA | EMEIS SA | N/A | 2.11B | ||
| GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 989.09M | ||
| RHK.DE | RHOEN-KLINIKUM AG | 21.79 | 816.91M | ||
| GHC.MI | GAROFALO HEALTH CARE SPA | 14.75 | 478.96M | ||
| M12.DE | M1 KLINIKEN AG | 16.91 | 312.28M | ||
| LNA.PA | LNA SANTE | 10.85 | 247.40M | ||
| LIK.DE | LIMES SCHLOSSKLINIKEN AG | 22.21 | 100.92M | ||
| EIF.DE | MEDNATION AG | 16.11 | 9.55M |
Related stock screener links
About MED.DE
Company Profile
MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg and currently employs 6,941 full-time employees. The company went IPO on 2000-12-04. The firm is engaged in providing professional medical servies in the fields of acute care (acute segment) and rehabilitation (post-acute segment), as well as nursing care services, through its hospitals. The company focuses on a range of services in the acture and post-acute segments, such as: neurology, neurological early rehabilitation, neurosurgery, psychosomatics and psychiatry, geriatrics, as well as orthopaedics. Other areas of special competencies are: tinnitus, cochlea implants and internal medicine (cardiology, pneumology, edocrinology), as well as the treatment of post- and long-COVID-19 symptoms.
Company Info
MEDICLIN AG
Okenstr. 27
Offenburg BADEN-WUERTTEMBERG DE
Employees: 6941
Phone: 497814880
MEDICLIN AG / MED.DE FAQ
What does MEDICLIN AG do?
MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg and currently employs 6,941 full-time employees. The company went IPO on 2000-12-04. The firm is engaged in providing professional medical servies in the fields of acute care (acute segment) and rehabilitation (post-acute segment), as well as nursing care services, through its hospitals. The company focuses on a range of services in the acture and post-acute segments, such as: neurology, neurological early rehabilitation, neurosurgery, psychosomatics and psychiatry, geriatrics, as well as orthopaedics. Other areas of special competencies are: tinnitus, cochlea implants and internal medicine (cardiology, pneumology, edocrinology), as well as the treatment of post- and long-COVID-19 symptoms.
What is the current price of MED stock?
The current stock price of MED.DE is 3.4 EUR. The price decreased by -1.16% in the last trading session.
Does MED stock pay dividends?
MEDICLIN AG (MED.DE) has a dividend yield of 1.16%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of MED stock?
MED.DE has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists MED stock?
MED.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is MEDICLIN AG worth?
MEDICLIN AG (MED.DE) has a market capitalization of 161.50M EUR. This makes MED.DE a Micro Cap stock.
MED.DE Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to MED.DE. When comparing the yearly performance of all stocks, MED.DE is one of the better performing stocks in the market, outperforming 90.77% of all stocks.
MED.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to MED.DE. MED.DE has an excellent profitability rating, but there are some minor concerns on its financial health.
MED.DE Financial Highlights
Over the last trailing twelve months MED.DE reported a non-GAAP Earnings per Share(EPS) of 0.74. The EPS increased by 414.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.4% | ||
| ROA | 3.85% | ||
| ROE | 14.15% | ||
| Debt/Equity | 1.69 |
MED.DE Forecast & Estimates
6 analysts have analysed MED.DE and the average price target is 4.79 EUR. This implies a price increase of 41% is expected in the next year compared to the current price of 3.4.
For the next year, analysts expect an EPS growth of 52.44% and a revenue growth 4.55% for MED.DE